- Easy Tracking In The Watchlist
Weaker technical forecast for Jasper Therapeutics, Inc. as stock downgraded to Sell Candidate
(Updated on Jul 31, 2026)
No changes to the price of Jasper Therapeutics, Inc. stock on the last trading day (Friday, 31st Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0118 to a day high of $0.0118. The price has been going up and down for this period, and there has been a -8.53% loss for the last 2 weeks.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.91% during the next 3 months and, with a 90% probability hold a price between $0.0068 and $0.0127 at the end of this 3-month period.
JSPRW Signals & Forecast
There are mixed signals in the stock today. The Jasper Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0127. On a fall, the stock will find some support from the short-term average at $0.0117. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Jasper Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.0107 and $0.0106. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Jasper Therapeutics, Inc. finds support just below today's level at $0.0107. If this is broken, then the next support from accumulated volume will be at $0.0106 and $0.0102.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 5.53%
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (JSPRW) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Jasper Therapeutics, Inc. to open at $0.0118, and during the day (based on 14 day Average True Range), to move between $0.0053 and $0.0183, which gives a possible trading interval of +/-$0.0130 (+/-243.58%) up or down from last closing price. If Jasper Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 243.58% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.0120 (1.69%) than the support at $0.0107 (9.32%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Jasper Therapeutics, Inc. will release earnings on Friday, August 07, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.271. We will update the financials statements for Jasper Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 156.13% in the first trading day after earnings release.
Is Jasper Therapeutics, Inc. stock A Buy?
Jasper Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-3.754
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $0.0118 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
JSPRW Performance
Trading levels for JSPRW
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0118 | - |
| R2 | 0.0118 | - |
| R1 | 0.0118 | - |
| Price | 0.0118 | |
| S1 | 0.0118 | - |
| S2 | 0.0118 | - |
| S3 | 0.0118 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0135 | 14.41% |
| R2 | 0.0130 | 10.17% |
| R1 | 0.0120 | 1.69% |
| Price | 0.0118 | |
| S1 | 0.0107 | -9.32% |
| S2 | 0.0106 | -10.17% |
| S3 | 0.0102 | -13.56% |
FAQ
Click here for our free guide on how to buy Jasper Therapeutics, Inc. Stock.
Buy JSPRW